For the third quarter of 2025, Addnode Group reported net sales decreased by 29 percent to SEK 1,311 million, impacted by currency effects of SEK -50 million, while currency-adjusted organic net sales decreased by 33 percent. EBITA amounted to SEK 149 million, but adjusted for early contract renewals of SEK 70 million, EBITA would have been SEK 219 million, with currency effects impacting EBITA by SEK -4 million. The EBITA margin was 11.4 percent. Operating profit decreased to SEK 74 million, resulting in an operating margin of 5.6 percent. Net profit for the period decreased to SEK 54 million, with earnings per share declining to SEK 0.40. Cash flow from operating activities improved to SEK -64 million. The company acquired Genus in Norway, FF Solutions in Brazil, operations from TPM and Repro Products in the USA, Solidcad in Canada, and X10D Solutions in Sweden, and extended credit facilities on more favorable terms.
Stable market, high rate of acquisition activity and improved efficiency
Third quarter July 1–September 30, 2025
Net sales decreased by 29 percent to SEK 1,311 m (1,859). Net sales were unchanged compared with the pro forma figure*. Net sales were impacted by currency effects of SEK -50 m (-34). Currency-adjusted organic net sales decreased by 33 percent.
EBITA amounted to SEK 149 m (200). Adjusted for the early contract renewals of SEK 70 m which was communicated in the previous interim report, EBITA would have been SEK 219 m (200). Currency effects had an impact of SEK -4 m ( -3 ) on EBITA. The EBITA margin was 11.4 percent (10.8).
Operating profit decreased to SEK 74 m (137), and the operating margin fell to 5.6 percent (7.4).
Net profit for the period decreased to SEK 54 m (97).
Earnings per share declined to SEK 0.40 (0.73).
Cash flow from operating activities improved to SEK -64 m (-133).
Acquisitions of Genus in Norway and FF Solutions in Brazil.
Acquisition of operations from TPM and Repro Products in the USA.
Events after the end of the reporting period
Acquisition of Solidcad in Canada.
Acquisition of X10D Solutions in Sweden.
Credit facilities extended on more favorable terms.
* Pro forma figure (net sales adjusted for comparison) has been adjusted to reflect a scenario in which the new transaction model for partner software and reclassification of third-party agreements had been in place in 2024. A pro forma table is presented on page 29 in this interim report.
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may contain inaccuracies, outdated information, or subjective interpretations. This content is intended for general informational purposes only and should not be considered professional advice or factual confirmation.
We encourage you to independently verify any information provided, especially if it will be relied upon for making decisions or taking action. Any reliance you place on this material is strictly at your own risk. The AI system that produced this content cannot assess the specifics of individual circumstances, and results may vary based on context and individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.